retatrutide new england journal of medicine An experimental drug nicknamed "Reta" produced greater weight loss than any GLP-1 currently on the market: https://bit.ly/4dQOfH7 retatrutide phase 2 trial new

This graduated dosing approach mirrors what we see with current GLP-1 treatments, where starting low and increasing gradually helps minimise side effects

Two compounds that are safe individually can produce emergent effects when combined, effects that neither compound would produce alone

Those who lose weight more gradually and maintain adequate nutrition are less likely to experience significant shedding

this one requires a direct question to [email protected]

Some surgeons recommend adjusting or temporarily pausing GLP-1 medications around the time of surgery due to considerations such as delayed gastric emptying and anesthesia safety

For dulaglutide and extended-release exenatide, take the missed dose if there are at least 3 days (72 hours) until your next scheduled injection